GCM Grosvenor sells Maplebear Inc. shares for $232 million

Tenaya Therapeutics stock rises after positive safety reviews for heart gene therapies

Author11 minutes ago 0

Teradyne stock holds Overweight rating at Cantor Fitzgerald despite guidance miss

Author24 minutes ago 0

Client Challenge

Author38 minutes ago 0

Teva CEO sees minimal impact from potential U.S. tariffs despite 'big ambiguity' in sector

Author2 hours ago 0